SCHEMBL319608

SCHEMBL319608

C=CC(=O)N(C)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.46
POLB P06746 1/20 0.46
KDM4E B2RXH2 1/20 0.46
FAAH O00519 1/20 0.44
PHGDH O43175 1/20 0.44
MGLL Q99685 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
AKT1 P31749 1/20 0.43
RAB9A P51151 3/20 0.43
LMNA P02545 2/20 0.43
NPC1 O15118 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MITF O75030 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10438892 0.98 KMT2A (0.44) KMT2APOLBKDM4EFAAHPHGDH
SCHEMBL14408213 0.93 KDM4E (0.41) KMT2APOLBKDM4EFAAHPHGDH
SCHEMBL3030247 0.87 CHRNB2 (0.38) KMT2APOLBKDM4EFAAHPHGDH
SCHEMBL3030249 0.85 KDM4E (0.40) KMT2APOLBKDM4EAKT1RAB9A
SCHEMBL10362074 0.83 ALDH1A1 (0.48) KMT2APOLBKDM4ERAB9ANPC1
SCHEMBL18229042 0.82 NPC1 (0.47) KMT2APOLBCA12CA1CA2
SCHEMBL17733130 0.82 TGM2 (0.37) KMT2APOLBKDM4EFAAHPHGDH
SCHEMBL7267715 0.82 ALDH1A1 (0.46) KMT2ARAB9ALMNASMN1; SMN2ALDH1A1
SCHEMBL587718 0.82 ALDH5A1 (0.45) KMT2AKDM4ELMNANPC1SMN1; SMN2
SCHEMBL1185399 0.81 KMT2A (0.47) KMT2APOLBKDM4EFAAHPHGDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 895 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026097750-A1 METHOD FOR SYNTHESIZING ARYL-SUBSTITUTED CHIRAL TETRAHYDROPYRAN RING BY MEANS OF DE-SYMMETRIZATION 杭州澳赛诺生物科技有限公司 2026-05-15 WO claimed
CN-120158238-A Adhesive and protective film thereof 中国乐凯集团有限公司 2025-06-17 CN claimed
CN-119907921-A Engineered particles as red blood cell mimics for hematology and compositions containing the same 弹弓生物科学公司 2025-04-29 CN claimed
CN-119101040-B Method for synthesizing aryl substituted chiral tetrahydropyran ring through desymmetrical synthesis 杭州澳赛诺医药技术有限公司 2025-03-21 CN claimed
CN-119101040-A Method for synthesizing aryl substituted chiral tetrahydropyran ring through desymmetrical synthesis 杭州澳赛诺医药技术有限公司 2024-12-10 CN claimed
CN-116987235-A Synthesis of filtrate reducer and preparation of ultrahigh-density solid-free drilling fluid system 西南石油大学 2023-11-03 CN claimed
CN-115850120-A Preparation method of alcohol alpha-carbon hydrogen bond alkylated compound 浙江工业大学 2023-03-28 CN claimed
CN-114923837-A Hydrogel particles with tunable optical properties and methods of using the same 弹弓生物科学公司 2022-08-19 CN claimed
CN-107615062-B Hydrogel particles with tunable optical properties and methods of using the same 弹弓生物科学公司 2022-03-18 CN claimed
US-10202366-B2 Methods of promoting wound healing using CRM1 inhibitors Karyopharm Therapeutics Inc. (US) 2019-02-12 US claimed
CN-1582312-A High refractive index aromatic-based prepolymer precursors BAUSCH & LOMB (US) 2005-02-16 CN claimed
US-20050009952-A1 Liquid inks comprising a stable organosol SAMSUNG ELECTRONICS CO. LTD. 2005-01-13 US claimed
US-20040264908-A1 Material for attenuating light signals with low reflectance in a fiber optic network FURUKAWA ELECTRIC NORTH AMERICA, INC. 2004-12-30 US claimed
US-20040229958-A1 Synthesis of N-methyl-N-phenylaminoacrolein CLARIANT LIFE SCIENCE MOLECULES (ITALIA) S.P.A. 2004-11-18 US claimed
EP-1477474-A1 Process for the synthesis of N-methyl-N-phenylaminoacrolein Clariant Life Science Molecules (Italia) SpA (IT) 2004-11-17 EP claimed
US-20020128349-A1 Liquid inks comprising a stable organosol S-PRINTING SOLUTION CO., LTD. (KR) 2002-09-12 US claimed
EP-1229057-A2 Organosol and liquid inks comprising the same Samsung Electronics Co., Ltd. (KR) 2002-08-07 EP claimed
EP-1205815-A1 Liquid inks comprising surface-treated colorant particles and manufacturing method thereof Samsung Electronics Co., Ltd. (KR) 2002-05-15 EP claimed
US-5698361-A DIAZONIUM COMPOUND, POLYMERIC BINDER; DURABILITY FUJI PHOTO FILM CO., LTD. (JP) 1997-12-16 US claimed
US-5278254-A Blends SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1994-01-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10202366-B2 Methods of promoting wound healing using CRM1 inhibitors XPO1, XPA, ERCC2 KMT2A 3570/4885POLB 2131/4885KDM4E 2116/4885
US-20040229958-A1 Synthesis of N-methyl-N-phenylaminoacrolein PFAS, NSUN2, PNMT KMT2A 892/4885POLB 1146/4885KDM4E 1229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.